articleTop 1% cited

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American Journal of Transplantation · 2007 · Vol. 7(9) · pp. 2106–2113

Anders Åsberg(University of Oslo)Atul Humar(University of Alberta)Halvor Rollag(University of Oslo)Alan G. Jardine(University of Glasgow)H. Mouas(Roche (Switzerland))Mark D. Pescovitz(Indiana University – Purdue University Indianapolis)Dino Sgarabotto(University of Padua)Murat Tuncer(Akdeniz University)Irene L. Noronha(Beneficência Portuguesa de São Paulo)Anders Hartmann✉(University of Oslo)

View via DOI Publisher page

Cytomegalovirus and herpesvirus research Herpesvirus Infections and Treatments Toxoplasma gondii Research StudiesValganciclovirGanciclovirMedicineCytomegalovirusInternal medicineGastroenterologyHuman cytomegalovirusSurgeryHerpesviridaeImmunology

MeSH terms

ValganciclovirAdministration, OralAdolescentAdultAgedAntiviral AgentsCytomegalovirus InfectionsCytomegalovirusDNA, ViralDouble-Blind MethodFemaleFollow-Up StudiesGraft RejectionGraft SurvivalHumans

Citations

423

FWCI

16.26

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients